サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1551526

牛乳房炎治療システムの世界市場

Bovine Mastitis Treatment System

出版日
ページ情報
英文 366 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
牛乳房炎治療システムの世界市場
出版日: 2024年09月10日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 366 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

牛乳房炎治療システムの世界市場は2030年までに23億米ドルに達する見込み

2023年に18億米ドルと推定される牛乳房炎治療システムの世界市場は、2023年から2030年にかけてCAGR 3.6%で成長し、2030年には23億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである抗生物質治療は、CAGR 4.2%を記録し、分析期間終了時には13億米ドルに達すると予測されます。その他の治療タイプセグメントの成長率は、分析期間中CAGR 2.9％と推定されます。

米国市場は4億9,090万米ドルと推定、中国はCAGR 7.0％で成長予測

米国の牛乳房炎治療システム市場は、2023年に4億9,090万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに4億8,440万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは7.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.2%と2.7%と予測されています。欧州では、ドイツがCAGR 1.9%で成長すると予測されています。

世界の牛乳房炎治療システム市場- 主要動向と促進要因のまとめ

牛乳房炎治療システムはどのように酪農に革命を起こしているのか？

牛乳房炎治療システムは、乳牛に影響を与える最も一般的で費用のかかる病気の1つに対して、的を絞った効率的で効果的なソリューションを提供することで、酪農に革命をもたらしています。乳腺の炎症である乳房炎は、乳生産量と乳質を著しく低下させ、酪農家に多大な経済的損失をもたらします。先進的な治療システムは、乳腺炎をより迅速かつ正確に診断・治療し、牛群の健康と酪農場の収益性の両方への影響を最小限に抑えるよう設計されています。これらのシステムには通常、乳房炎の初期兆候を検出し、タイムリーな介入を可能にする診断ツールと、抗生物質やその他の治療薬を患部に直接投与する治療装置が含まれています。治療プロセスを自動化し、それぞれの牛が適切な治療を受けられるようにすることで、これらのシステムは動物福祉を向上させるだけでなく、乳生産効率を高め、広域抗生物質の使用を減らし、より持続可能な酪農経営に貢献します。

どのような技術革新が牛乳房炎治療システムの機能性を高めているのか？

牛の乳房炎治療システムの技術革新は、診断、精密治療、データ統合の進歩を通じて、その機能性を高めています。最新のシステムには、センサーや農場内検査キットなどのリアルタイム診断技術が搭載されるようになってきており、乳房炎をその初期段階、多くの場合は臨床症状が現れる前に検出することができます。これらの技術により、酪農家は罹患牛をより迅速に隔離・治療し、牛群内での感染拡大を防ぐことができます。自動注入システムなどの精密治療装置は、抗生物質や抗炎症剤を感染した乳房に直接投与することで、過剰治療のリスクを減らし、抗生物質耐性を最小限に抑えることができます。さらに、これらの治療システムは農場管理ソフトウェアと統合され、シームレスなデータ収集と分析を可能にしています。この統合により、酪農家は各牛の健康状態を追跡し、治療結果をモニターし、牛群管理について情報に基づいた決定を下すことができます。このような技術革新により、牛の乳房炎治療システムはより効果的で効率的なものとなり、精密農業や持続可能な農法が重視されるようになってきています。

牛乳房炎治療システムは酪農生産と動物福祉にどのような影響を与えるのか？

牛乳房炎治療システムは、乳牛の健康を改善し、生産されるミルクの質と量を向上させることで、酪農生産と動物福祉に大きな影響を与えます。乳房炎の早期発見と的を絞った治療を可能にすることで、これらのシステムは乳房炎の重症度と罹病期間を減らし、乳生産ロスを最小限に抑え、牛群全体の生産性を向上させます。健康な牛はより高品質の乳を生産し、これは業界の基準を満たし、収益性を最大化するために不可欠です。さらに、精密治療法の使用は抗生物質への依存を減らし、より良い動物の健康を促進し、抗生物質耐性と闘う世界の取り組みに貢献します。動物福祉の観点からは、これらのシステムは牛がタイムリーで適切なケアを受けられることを保証し、乳房炎に伴う痛みや不快感を軽減します。このように動物の健康と福祉に重点を置くことは、倫理的な農業慣行と一致するだけでなく、より健康で生産性の高い牛群を育成することで、酪農経営の長期的な持続可能性を高めることにもなります。

牛乳房炎治療システム市場の成長を促進する動向とは？

精密農業技術の採用の増加、抗生物質耐性に対する意識の高まり、動物福祉と持続可能な農業への関心の高まりなど、いくつかの動向が牛乳房炎治療システム市場の成長を促進しています。酪農家が経営効率と収益性の向上を目指す中、牛群の健康状態をより正確に管理できる高度な技術への需要が高まっています。早期発見と的を絞った治療を提供する牛乳房炎治療システムは、精密農業に向けたこの動向の一環として、ますます人気が高まっています。抗生物質耐性に対する世界の懸念も市場に影響を及ぼしており、規制当局と消費者の両方が家畜への抗生物質使用の削減を推進しています。このため、抗生物質をより適切に使用し、耐性を助長することなく効果的な治療を行えるシステムの導入が進んでいます。さらに、動物福祉と持続可能な農法が重視され、乳牛の健康と福祉を向上させるシステムの開発と使用が奨励されています。これらの動向は、効率性、持続可能性、動物の健康が重要な優先事項である酪農の将来において、牛乳房炎治療システムの重要性が高まっていることを浮き彫りにしています。

調査対象企業の例（全42件）

  • Armenta Ltd.
  • Boehringer Ingelheim International GmbH
  • HIPRA, S.A.
  • Huvepharma EOOD
  • ImmuCell Corporation
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Thermo Fisher Scientific India Pvt. Ltd.
  • Vetoquinol SA
  • Virbac S.A.
  • West Way Health
  • Zoetis Inc.;

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP24604

Global Bovine Mastitis Treatment System Market to Reach US$2.3 Billion by 2030

The global market for Bovine Mastitis Treatment System estimated at US$1.8 Billion in the year 2023, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2023-2030. Antibiotics Treatment, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Other Treatment Types segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$490.9 Million While China is Forecast to Grow at 7.0% CAGR

The Bovine Mastitis Treatment System market in the U.S. is estimated at US$490.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$484.4 Million by the year 2030 trailing a CAGR of 7.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Bovine Mastitis Treatment System Market - Key Trends and Drivers Summarized

How Is Bovine Mastitis Treatment System Revolutionizing Dairy Farming?

Bovine mastitis treatment systems are revolutionizing dairy farming by providing targeted, efficient, and effective solutions to one of the most common and costly diseases affecting dairy cattle. Mastitis, an inflammation of the mammary gland, can significantly reduce milk production and quality, leading to substantial economic losses for dairy farmers. Advanced treatment systems are designed to diagnose and treat mastitis more quickly and accurately, helping to minimize the impact of the disease on both the herd's health and the farm's profitability. These systems typically include diagnostic tools that detect early signs of mastitis, enabling timely intervention, and treatment devices that deliver antibiotics or other therapies directly to the affected area. By automating the treatment process and ensuring that each cow receives the appropriate care, these systems not only improve animal welfare but also enhance milk production efficiency, reduce the use of broad-spectrum antibiotics, and contribute to more sustainable dairy farming practices.

What Innovations Are Enhancing the Functionality of Bovine Mastitis Treatment Systems?

Innovations in bovine mastitis treatment systems are enhancing their functionality through advancements in diagnostics, precision treatment, and data integration. Modern systems are increasingly incorporating real-time diagnostic technologies, such as sensors and on-farm testing kits, that can detect mastitis at its earliest stages, often before clinical symptoms are visible. These technologies enable farmers to isolate and treat affected cows more quickly, preventing the spread of infection within the herd. Precision treatment devices, such as automated infusion systems, allow for targeted delivery of antibiotics or anti-inflammatory agents directly to the infected udder quarters, reducing the risk of overtreatment and minimizing antibiotic resistance. Additionally, these treatment systems are being integrated with farm management software, enabling seamless data collection and analysis. This integration allows farmers to track the health of each cow, monitor treatment outcomes, and make informed decisions about herd management. These innovations are making bovine mastitis treatment systems more effective, efficient, and aligned with the growing emphasis on precision agriculture and sustainable farming practices.

How Do Bovine Mastitis Treatment Systems Impact Dairy Production and Animal Welfare?

Bovine mastitis treatment systems have a significant impact on dairy production and animal welfare by improving the health of dairy cows and enhancing the quality and quantity of milk produced. By enabling early detection and targeted treatment of mastitis, these systems help reduce the severity and duration of the disease, which in turn minimizes milk production losses and improves the overall productivity of the herd. Healthier cows produce higher quality milk, which is essential for meeting industry standards and maximizing profitability. Moreover, the use of precision treatment methods reduces the reliance on antibiotics, promoting better animal health and contributing to the global effort to combat antibiotic resistance. From an animal welfare perspective, these systems ensure that cows receive timely and appropriate care, reducing pain and discomfort associated with mastitis. This focus on animal health and well-being not only aligns with ethical farming practices but also enhances the long-term sustainability of dairy operations by fostering a healthier, more productive herd.

What Trends Are Driving Growth in the Bovine Mastitis Treatment Systems Market?

Several trends are driving growth in the bovine mastitis treatment systems market, including the increasing adoption of precision farming technologies, growing awareness of antibiotic resistance, and the rising focus on animal welfare and sustainable agriculture. As dairy farmers seek to improve operational efficiency and profitability, there is a growing demand for advanced technologies that enable more precise management of herd health. Bovine mastitis treatment systems that offer early detection and targeted therapy are becoming increasingly popular as part of this trend towards precision farming. The global concern over antibiotic resistance is also influencing the market, as both regulators and consumers push for reduced antibiotic use in livestock. This is driving the adoption of systems that allow for more judicious use of antibiotics, ensuring effective treatment without contributing to resistance. Additionally, the emphasis on animal welfare and sustainable farming practices is encouraging the development and use of systems that improve the health and well-being of dairy cows, which in turn supports more sustainable and ethical dairy production. These trends highlight the growing importance of bovine mastitis treatment systems in the future of dairy farming, where efficiency, sustainability, and animal health are key priorities.

Select Competitors (Total 42 Featured) -

  • Armenta Ltd.
  • Boehringer Ingelheim International GmbH
  • HIPRA, S.A.
  • Huvepharma EOOD
  • ImmuCell Corporation
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Thermo Fisher Scientific India Pvt. Ltd.
  • Vetoquinol SA
  • Virbac S.A.
  • West Way Health
  • Zoetis Inc.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Bovine Mastitis Treatment System - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Bovine Mastitis Driving Demand for Effective Treatment Solutions
    • Advancements in Diagnostic Technologies Enhancing Early Detection and Management
    • Development of Antibiotic-Free Treatments in Response to Consumer Health Concerns
    • Global Dairy Industry Growth and Its Impact on Mastitis Management Demand
    • Integration of Precision Farming Techniques to Improve Herd Health
    • Adoption of Telemedicine and Digital Tools for Veterinary Care
    • Technological Advances in Milking Systems and Their Role in Mastitis Prevention
    • Future Directions in Genomics and Breeding for Mastitis Resistance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bovine Mastitis Treatment System Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bovine Mastitis Treatment System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Bovine Mastitis Treatment System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Antibiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Intra-Mammary Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Intra-Mammary Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Intra-Mammary Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Systemic Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Systemic Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Systemic Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for On-Site Treatment End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for On-Site Treatment End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for On-Site Treatment End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Veterinary Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Veterinary Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Veterinary Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • JAPAN
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • CHINA
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • EUROPE
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Bovine Mastitis Treatment System by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Bovine Mastitis Treatment System by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • FRANCE
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • GERMANY
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: UK 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 107: Spain Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Spain Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Spain 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Spain 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 116: Russia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Russia Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Russia 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Russia 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Bovine Mastitis Treatment System by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Bovine Mastitis Treatment System by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 146: Australia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Australia Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Australia 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Australia 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • INDIA
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 155: India Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: India Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: India 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 158: India Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: India 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 164: South Korea Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: South Korea Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: South Korea 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: South Korea 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 173: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Asia-Pacific Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Asia-Pacific 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 182: Latin America Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 183: Latin America Historic Review for Bovine Mastitis Treatment System by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Latin America 16-Year Perspective for Bovine Mastitis Treatment System by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Latin America 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 194: Argentina Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Argentina Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Argentina 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Argentina 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 203: Brazil Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Brazil Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Brazil 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Brazil 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 212: Mexico Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Mexico Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Mexico 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Mexico 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 221: Rest of Latin America Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Rest of Latin America Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Rest of Latin America 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Rest of Latin America 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 230: Middle East Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 231: Middle East Historic Review for Bovine Mastitis Treatment System by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Middle East 16-Year Perspective for Bovine Mastitis Treatment System by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Middle East 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 242: Iran Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Iran Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Iran 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Iran 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 251: Israel Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Israel Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Israel 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Israel 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 260: Saudi Arabia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Saudi Arabia Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Saudi Arabia 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Saudi Arabia 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 269: UAE Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: UAE Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: UAE 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: UAE 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 278: Rest of Middle East Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Rest of Middle East Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: Rest of Middle East 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: Rest of Middle East 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • AFRICA
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 287: Africa Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Africa Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: Africa 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Africa 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION